PE20010041A1 - Derivados de 1-aminoetilindol, su preparacion y su aplicacion en terapeutica - Google Patents

Derivados de 1-aminoetilindol, su preparacion y su aplicacion en terapeutica

Info

Publication number
PE20010041A1
PE20010041A1 PE2000000344A PE0003442000A PE20010041A1 PE 20010041 A1 PE20010041 A1 PE 20010041A1 PE 2000000344 A PE2000000344 A PE 2000000344A PE 0003442000 A PE0003442000 A PE 0003442000A PE 20010041 A1 PE20010041 A1 PE 20010041A1
Authority
PE
Peru
Prior art keywords
alkyl
aminoethylindol
derivatives
fluoroalkyl
hydroxyethyl
Prior art date
Application number
PE2000000344A
Other languages
English (en)
Inventor
Philippe R Bovy
Patrick Mougenot
Philippo Christophe
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of PE20010041A1 publication Critical patent/PE20010041A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

SE REFIERE A DERIVADOS DE 1-AMINOETILINDOL DE FORMULA I, DONDE: A ES H, HALOGENO, HIDROXI; B Y D SON H, ALQUILO C1-C3; R1 ES H, ALQUILO C1-C4, FLUOROALQUILO C1-C2, PERFLUOROALQUILO C1-C2; R2 ES H, HALOGENO, ALQUILO C1-C6, CICLOALQUILO C3-C6, FLUOROALQUILO C1-C2, PERFLUOROALQUILO, FENILO; R3 Y R4 SON H, HALOGENO, ALQUILO C1-C6; R5 Y R6 SON H, ALQUILO C1-C6, FLUOROALQUILO C1-C2; R5 Y R6 JUNTOS SON ALQUILENO C2-C7. SON COMPUESTOS PREFERIDOS 2-METILINDOL-4-(1-DIETILAMINO-2-HIDROXIETIL)INDOL, 1(N)-METIL-2-ETILINDOL-4-(1-DIETILAMINO-2-HIDROXIETIL)INDOL, 1(N)-METIL-2-FENIL-4-(1-DIETILAMINO-2-HIDROXIETIL)INDOL, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA PREPARACION. LOS DERIVADOS DE 1-AMINOETILINDOL DE FORMULA I TIENEN ACCION CONTRACTIL SOBRE LOS MUSCULOS LISOS URETRALES Y ARTERIALES Y PUEDEN SER UTILES PARA EL TRATAMIENTO DE INCONTINENCIA URINARIA DE ESFUERZO, INSUFICIENCIA VENOSA, MIGRANA, TRASTORNOS GASTROINTESTINALES
PE2000000344A 1999-04-13 2000-04-13 Derivados de 1-aminoetilindol, su preparacion y su aplicacion en terapeutica PE20010041A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9904577A FR2792316B1 (fr) 1999-04-13 1999-04-13 Derives de 1-aminoethylindole, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
PE20010041A1 true PE20010041A1 (es) 2001-04-12

Family

ID=9544316

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000344A PE20010041A1 (es) 1999-04-13 2000-04-13 Derivados de 1-aminoetilindol, su preparacion y su aplicacion en terapeutica

Country Status (7)

Country Link
AR (1) AR023451A1 (es)
AU (1) AU3971400A (es)
CO (1) CO5180549A1 (es)
FR (1) FR2792316B1 (es)
PE (1) PE20010041A1 (es)
UY (1) UY26102A1 (es)
WO (1) WO2000061554A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR077405A1 (es) 2009-07-10 2011-08-24 Sanofi Aventis Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2752839B1 (fr) * 1996-08-29 1998-10-09 Synthelabo Derives de benzofurane, leur preparation et leur application en therapeutique
FR2752840A1 (fr) * 1996-08-29 1998-03-06 Synthelabo Derives de benzothiophene, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
AR023451A1 (es) 2002-09-04
UY26102A1 (es) 2000-10-31
WO2000061554A1 (fr) 2000-10-19
FR2792316B1 (fr) 2001-06-22
AU3971400A (en) 2000-11-14
CO5180549A1 (es) 2002-07-30
FR2792316A1 (fr) 2000-10-20

Similar Documents

Publication Publication Date Title
AR031627A1 (es) Activadores heteroaromaticos fusionados de la glucoquinasa
DK1713480T3 (da) Anvendelse af kvaternære pyridiniumsalte som vasobeskyttende midler
HRP20090162T1 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
ATE72436T1 (de) 2-(methyl(4-piperidinyl)>-1,2,3,4-tetrahydro-9h pyrido(3,4-b>indolderivate, ihre herstellung und therapeutische verwendung.
PE20030762A1 (es) Compuestos heterociclicos como antagonistas nk1
PE20020721A1 (es) Derivados de quinuclidina como agentes antimuscarinicos m3
PE20011371A1 (es) Derivados de 3-(3-isopropil-5-metil-4h-1,2,4-triazol-4-il)-exo-8-azabiciclo[3.2.1]octano como antagonistas de los receptores de quimiocina ccr5
YU66201A (sh) Derivati amina kao inhibitori proteaze
UY24206A1 (es) Feniliminoimidazolinas agonistas de alfa 1l útiles en el tratamiento de la incontinencia urinaria.
PE10897A1 (es) Compuestos benzo fusionados
PE20030447A1 (es) Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol-3-il)-sustituidos y su obtencion
PE20010402A1 (es) Derivados de 1,5-dihidropirrol-2-ona sustituida
PE29798A1 (es) Acetidinas
ES520860A0 (es) Procedimiento de preparar teofilinas 7-substituidas.
PE20010041A1 (es) Derivados de 1-aminoetilindol, su preparacion y su aplicacion en terapeutica
DE69103968D1 (de) 2-(Aminoalkyl)-5-(arylalkyl)1,3-dioxanderivate, ihre Herstellung und ihre Anwendung in der Therapeutik.
TR200200969T2 (tr) Karbonilamino türevlerinin CNS bozukluklarına karşı kullanılması
AR037880A1 (es) Derivados de benzodifuranimidazolina y benzofuranimidazolina y su uso para el tratamiento de glaucoma
DK0783495T3 (da) Quinoxalinderivater, der er egnede i terapi
PE20011230A1 (es) Derivados de imidazol como agonistas de alfa- 2- adrenoreceptores
PE20001596A1 (es) Derivados de morfolina
ATE297926T1 (de) Hexahydropyrazino(1'2':1,6)-pyrido(3,4-b)indole 1,4-dion-derivate zur behandlung von cardiovaskulären erkrankungen und erektionsstörungen
SE8804003D0 (sv) Compounds for the treatment of urinary incontinence
ATE336487T1 (de) Benzoesaüre derivate und deren verwendung
NZ332029A (en) Sulfonamide substituted chromans, process for their preparation, their use as a medicament and pharmaceutical preparations comprising them

Legal Events

Date Code Title Description
FA Abandonment or withdrawal